Agenda for the May 2025 PBAC Meeting
18 Dec 2024
The agenda for the May 2025 Pharmaceutical Benefits Advisory Committee (PBAC) meeting is now available.
The public consultation for the May 2025 PBAC Meeting will be available on the Office of Health Technology Assessment (OHTA) Consultation Hub from 30 January 2025 until 26 March 2025. The earlier publication of the agenda provides greater awareness of the medicines and vaccines being considered by the PBAC, whilst the 8-week timeline to submit your input is in keeping with standard practice for PBAC meetings.
Your input is valued. Whether you are a patient, carer, member of the public, health professional or member of a consumer interest group, your input for a medicine or vaccine under consideration will inform PBAC decision-making. Further information about the PBAC process and how to provide input can be found on the Office of Health Technology Assessment (OHTA) Consultation Hub.
Categories
- MBS
- PBS
- The Department Of Health And Aged Care
- RACGP
- NIP
- AHPRA
- NSW Health
- Queensland Health
- Victoria Health
- Tasmania News
- Western Australia
- SA Health
- NT HEALTH
- Pharmacy Board Of Ahpra
- National Asthma Council
- NT
- AMA
- NACCHO
- BCNA
- Australian College Of Nurse Practitioners
- Asthma Australia
- LFA
- Palliative Care
- Primary Health Network
- AIHW
- Children's Health Queenland
- Kidney Health
- CHF
- MHC
- Gold Coast
- Tsa
- TGA
- Medicine Shortage
Popular Posts
Tags
- Environmental health National Health and Climate Strategy environmental-health-national-health-and-climate-strategy
